Navigation Links
Cannabis to be tested to help patients with respiratory diseases

"All substances are poisonous, there is none which is not a poison; the right dose differentiates a poison from a remedy" Paracelsus, circa 1538

Breathlessness can have a major impact on the quality of life for patients with respiratory diseases. //Despite the best efforts of scientists for many years, no one has been able to develop a way to deal with the sensation of breathlessness without suppressing the drive to breathe. Researchers from Imperial College London are looking for volunteers to test whether cannabinoids, the active ingredient of cannabis, can be used to alleviate the sensation of breathlessness caused by illnesses such as chronic obstructive pulmonary disease (COPD).

The team is looking for volunteers aged between 50 and 70, who don't have breathing difficulties. The volunteers will be hooked up to a circuit to regulate and measure their breathing. Carbon dioxide will be added to the air breathed by the volunteers, causing the sensation of breathlessness. This is a safe method of simulating breathlessness as the body naturally produces carbon dioxide.

Afterwards the volunteers will be given a spray, which includes tetrahydrocannabinol (THC), the active ingredient in cannabis, which is hoped to reduce the sensation of breathlessness.

The special formulation of the drug as a spray avoids the harmful effects of smoking cannabis. We hope the drug will stop the sensation of breathlessness, potentially providing a new way to deal with respiratory diseases.


'"/>




Page: 1

Related medicine news :

1. Cannabis for pain
2. Cannabis exerts protective effect against cancer
3. Relief For British MS Patients: Cannabis-Based Oral Spray
4. Alcohol And Drug Abuse (Cannabis) Leading Causes For Road Traffic Accidents
5. Government May Downgrade Cannabis
6. Can Cannabis Cause Madness?
7. Campaigners Say No To Cannabis Reclassification
8. No Increased Schizophrenia Risk With Use Of Cannabis
9. Tackling of Cannabis Addiction
10. Australia Set To Implement A national Strategy Tackle Cannabis Abuse
11. Beware of Cannabis - Not at all a mild drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... December 06, 2016 , ... It can be argued that people these days ... members as they do for their human friends and family. As pets have ... highest quality and most innovative pet products has also increased. , For ...
(Date:12/6/2016)... ... December 06, 2016 , ... The Behavioral Health Center ... recognizing the organization as a top behavioral service provider in the country. The ... quality, staff satisfaction and qualifications, and consumer satisfaction. These areas are measured via ...
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway Analytical, one of ... particle counting and sizing services for USP 788 and 789 particulate standards compliance. ... as a response to the needs of pharmaceutical and medical device manufacturers, who ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... Vancouver, B.C., Canada (PRWEB) , ... December 06, ... ... Consultants (STC) announce the availability of the newly updated International Audit Protocol Consortium ... world use IAPC EHS audit protocols to understand the scope of their EHS ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... N.J. , Dec. 5, 2016  Daiichi ... preliminary safety and efficacy data from a phase ... MDM2 inhibitor, suggesting that DS-3032 may be a ... myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). ... the phase 1 study of DS-3032 were presented in ...
(Date:12/5/2016)... -- BD (Becton, Dickinson and Company) (NYSE: BDX ... an enhanced technology platform designed with the ability to ... Pyxis™ and Alaris™ systems, at this year,s American ... being held in Las Vegas ... that approximately 68 percent of medication errors occur during ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. ... at the 2016 Annual Meeting of the American Epilepsy ... CIII, is indicated as an adjunctive therapy for the ... secondarily generalized seizures and primary generalized tonic-clonic seizures (PGTC) ... age and older. Please see Important Safety Information for ...
Breaking Medicine Technology: